Literature DB >> 12835239

Interface between authorship, industry and science in the domain of therapeutics.

David Healy1, Dinah Cattell.   

Abstract

BACKGROUND: Changes in the character of medical authorship. Aims To compare the impact of industry-linked and non-industry linked articles.
METHOD: We compared articles on sertraline being coordinated by a medical writing agency with articles not coordinated in this way. We calculated numbers of Medline-listed articles per author, journal impact factors, literature profiles and citation rates of both sets of articles.
RESULTS: Non-agency-linked articles on sertraline had an average of 2.95 authors per article, a mean length of 3.4 pages, a mean Medline listing of 37 articles per author (95% CI 27-47) and a mean literature profile of 283 per article (95% CI 130-435). Agency-linked articles on sertraline had an average of 6.6 authors per article, a mean length of 10.7 pages, a mean Medline listing of 70 articles per author (95% CI 62-79) and a mean literature profile of 1839 per article (95% CI 1076-2602). The citation rate for agency articles was 20.2 (95% CI 13.4-27.0) and for non-agency articles it was 3.7 (95% CI 3.3-8.1).
CONCLUSIONS: The literature profiles and citation rates of industry-linked and non-industry-linked articles differ. The emerging style of authorship in industry-linked articles can deliver good-quality articles, but it raises concerns for the scientific base of therapeutics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835239

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  37 in total

1.  Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO.

Authors:  Kay Dickersin; Iain Chalmers
Journal:  J R Soc Med       Date:  2011-12       Impact factor: 5.344

2.  Partisan perspectives in the medical literature: a study of high frequency editorialists favoring hormone replacement therapy.

Authors:  Athina Tatsioni; George C M Siontis; John P A Ioannidis
Journal:  J Gen Intern Med       Date:  2010-04-28       Impact factor: 5.128

3.  The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Authors:  O Bruyere; J A Kanis; M-E Ibar-Abadie; N Alsayed; M L Brandi; N Burlet; D L Cahall; A Chines; J-P Devogelaer; W Dere; N Goel; N Hughes; J-M Kaufman; S Korte; B H Mitlak; D Niese; R Rizzoli; L C Rovati; J-Y Reginster
Journal:  Osteoporos Int       Date:  2010-03-18       Impact factor: 4.507

4.  Transparency and trust: figure for ghost written articles was misquoted.

Authors:  David T Healy
Journal:  BMJ       Date:  2004-12-04

5.  Manufacturing consensus.

Authors:  David Healy
Journal:  Cult Med Psychiatry       Date:  2006-06

Review 6.  Ethical issues in psychopharmacology.

Authors:  L McHenry
Journal:  J Med Ethics       Date:  2006-07       Impact factor: 2.903

7.  One flew over the conflict of interest nest.

Authors:  David Healy
Journal:  World Psychiatry       Date:  2007-02       Impact factor: 49.548

8.  Rethinking medical professionalism: the role of information technology and practice innovations.

Authors:  David Mechanic
Journal:  Milbank Q       Date:  2008-06       Impact factor: 4.911

9.  Ghostwriting at elite academic medical centers in the United States.

Authors:  Jeffrey R Lacasse; Jonathan Leo
Journal:  PLoS Med       Date:  2010-02-02       Impact factor: 11.069

10.  The haunting of medical journals: how ghostwriting sold "HRT".

Authors:  Adriane J Fugh-Berman
Journal:  PLoS Med       Date:  2010-09-07       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.